A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis

To minimize the need for antibiotic treatments and prevent drug resistance, it is crucial to reduce the number of people at risk of tuberculosis and other infectious diseases. Addressing undernutrition, infection prevention, control measures, vaccine access, and strengthening water, sanitation, and hygiene services can significantly reduce infections and antibiotic prescriptions. Member States must commit to developing and funding national diagnostic and surveillance strategies to ensure data-driven decision-making. Universal access to quality antibiotic treatments is essential, as 3 million people with drug-sensitive tuberculosis did not access proper diagnosis and treatment in 2022. Member States must set targets to increase access to effective, safe, narrow-spectrum antibiotics and reduce inappropriate prescribing across public, private, and informal health-care systems. Innovation must keep pace with AMR, addressing key research gaps and ensuring the global response keeps pace with scientific progress. A robust AMR response is necessary to eliminate tuberculosis and ensure an aligned global public health agenda.